ICU Medical, Inc.
ICUI
$147.87
$0.890.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.84% | 2.96% | 7.22% | 5.44% | 4.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.84% | 2.96% | 7.22% | 5.44% | 4.04% |
| Cost of Revenue | -6.17% | -2.18% | 3.04% | 2.50% | 4.31% |
| Gross Profit | 10.04% | 13.65% | 15.90% | 11.48% | 3.48% |
| SG&A Expenses | -0.99% | 2.86% | 4.34% | 5.29% | 6.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.50% | -0.71% | 3.40% | 3.32% | 4.88% |
| Operating Income | 181.65% | 214.95% | 257.94% | 103.62% | -25.77% |
| Income Before Tax | 126.84% | 116.17% | 60.51% | 15.69% | -75.87% |
| Income Tax Expenses | 38,183.51% | 291.74% | 226.39% | 206.23% | 100.28% |
| Earnings from Continuing Operations | 93.37% | 47.80% | -57.96% | -296.86% | -295.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 93.37% | 47.80% | -57.96% | -296.86% | -295.83% |
| EBIT | 181.65% | 214.95% | 257.94% | 103.62% | -25.77% |
| EBITDA | 23.23% | 24.75% | 27.53% | 14.57% | -7.13% |
| EPS Basic | 93.27% | 47.92% | -56.19% | -292.15% | -290.68% |
| Normalized Basic EPS | 163.36% | 138.07% | 117.87% | 76.47% | -75.64% |
| EPS Diluted | 92.95% | 47.54% | -56.62% | -292.64% | -290.49% |
| Normalized Diluted EPS | 163.31% | 138.10% | 117.90% | 76.42% | -76.30% |
| Average Basic Shares Outstanding | 1.20% | 1.27% | 1.34% | 1.23% | 1.02% |
| Average Diluted Shares Outstanding | 1.27% | 1.09% | 1.09% | 0.98% | 0.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |